Cleared Traditional

K153019 - Disposable Adhesive Surface Electrodes, Disposable/Reusable Cup Electrodes

K153019 is an FDA 510(k) clearance for Disposable Adhesive Surface Electrodes, manufactured by Bio Protech, Inc.. The device is a Class 2 Neurology device with product code GXY cleared through the Traditional 510(k) pathway after a 158-day FDA review.

K153019 · Bio Protech, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
158d
Days
Class 2
Risk

K153019 is an FDA 510(k) clearance for the Disposable Adhesive Surface Electrodes, Disposable/Reusable Cup Electrodes. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Bio Protech, Inc. (Wonju-Si, KR). The FDA issued a Cleared decision on March 21, 2016 after a review of 158 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Bio Protech, Inc. devices

FDA 510(k) Submission Details - K153019

510(k) Number K153019 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2015
Decision Date March 21, 2016
Days to Decision 158 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 148d · This submission: 158d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXY Device Classification - Class 2, Special Controls

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Bio Protech USA, Inc.
KEVIN HAN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GXY Electrode, Cutaneous

All 290
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K153019.
FlexStim Neurostimulation Electrodes Model Numbers: 5050ROC1S, 5050ROC1W, 5050ROC2S, 5050ROC2W, 5050SQC1S, 5050SQC1W, 5050SQC2S, 5050SQC2W
K161282 · Medico Electrodes International , Ltd. · Oct 2016
TENS Electrodes
K160081 · Cathay Manufacturing Corp. · Oct 2016
Adhesive Electrodes
K160138 · Gmdasz Manufacturing Co., Ltd. · Aug 2016
Mailuokang Self-adhesive Electrode
K152815 · Shenzhen Mailuokang Technology Co., Ltd. · Mar 2016
Ennova Self-adhesive Electrode
K152648 · Suzhou Ennova Electronics Technology Co.,Ltd · Feb 2016
Dr-Ho's Foot Pad Electrode
K151693 · Drtv Asia, Ltd. · Oct 2015